Skip to main content
logo
Medtronic plc (MDT)
NYSE: MDT · Real-Time Price · USD
96.86
-0.72 (-0.74%)
At close: Feb 20, 2026, 4:00 PM EST
97.00
+0.14 (0.15%)
After-hours: Feb 20, 2026, 7:56 PM EST

Medtronic Revenue by Segment

Period EndingDec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020
Cardiovascular
13.51B13.09B12.76B12.48B12.28B12.17B11.99B11.83B
Cardiovascular Growth
10.08%7.61%6.43%5.49%2.27%2.71%2.50%2.35%
Neuroscience
10.16B10.06B9.95B9.85B9.77B9.67B9.51B9.41B
Neuroscience Growth
3.94%4.01%4.63%4.67%5.38%5.49%4.88%5.00%
Medical Surgery
8.64B8.54B8.50B8.41B8.39B8.47B8.48B8.53B
Medical Surgery Growth
2.92%0.80%0.13%-1.40%-0.70%0.33%1.36%2.34%
Diabetes
3.00B2.90B2.83B2.76B2.69B2.63B2.56B2.49B
Diabetes Growth
11.72%10.14%10.64%10.73%10.90%11.90%11.22%9.99%
Other
171.00M171.00M173.00M48.00M74.00M59.00M44.00M112.00M-------------
Other Growth
131.08%189.83%293.18%-57.14%-----------------

Revenue by Geography

Period EndingDec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018
United States
17.78B17.52B17.31B17.17B16.97B16.85B16.72B16.56B
United States Growth
4.80%4.01%3.54%3.67%1.62%1.27%1.14%1.15%
Rest of World
17.70B17.23B16.89B16.37B16.23B16.15B15.86B15.80B
Rest of World Growth
9.06%6.74%6.51%3.58%3.90%5.40%5.52%6.38%

Operating Expense Breakdown

Period EndingDec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022
Selling, General, and Administrative
11.45B11.21B11.00B10.85B10.89B10.85B10.78B10.74B
Selling, General, and Administrative Growth
5.09%3.31%2.06%1.05%2.89%3.04%3.04%3.09%
Research and Development
2.89B2.84B2.78B2.73B2.72B2.74B2.74B2.74B
Research and Development Growth
5.99%3.50%1.38%-0.15%0.81%1.82%2.69%1.48%
Amortization
1.93B1.90B1.85B1.81B1.66B1.67B1.68B1.69B
Amortization Growth
15.94%14.23%10.44%6.80%-2.00%-2.52%-1.58%-0.35%
Litigation
325.00M-344.00M361.00M212.00M-230.00M119.00M-110.00M79.00M----
Litigation Growth
41.30%-189.08%228.18%168.35%-253.85%--------
Restructuring
279.00M245.00M265.00M267.00M232.00M209.00M219.00M226.00M
Restructuring Growth
20.26%17.22%21.00%18.14%-43.14%-50.94%-47.36%-39.89%
Other Expenses
142.00M102.00M46.00M-23.00M439.00M461.00M464.00M464.00M
Other Expenses Growth
-67.65%-77.87%-90.09%-920.93%---
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.